Slowing kidney disease comes down to reducing the physical stress on your kidneys’ filtering units and treating the conditions that damage them. The most effective strategies combine medication, dietary changes, and lifestyle adjustments, and starting early makes a significant difference. Even in later stages, the right approach can meaningfully delay or prevent the need for dialysis.
Why Kidney Disease Gets Worse Over Time
Understanding what drives progression helps explain why the treatments below work. When kidney tissue is damaged, whether from diabetes, high blood pressure, or another cause, the remaining healthy filtering units (called nephrons) have to pick up the slack. Each surviving nephron filters more blood than it was designed to handle. This compensatory overdrive, known as hyperfiltration, is initially helpful but eventually becomes destructive.
The extra pressure stretches and damages the delicate structures inside each nephron. Over time, this mechanical stress causes scarring, protein leakage into the urine, and further nephron loss, which forces the remaining nephrons to work even harder. It’s a self-reinforcing cycle. Nearly every intervention for slowing kidney disease targets some part of this loop: lowering the pressure inside the kidneys, reducing inflammation, or limiting the metabolic waste the kidneys have to process.
Blood Pressure Medications That Protect the Kidneys
Two classes of blood pressure medication do double duty: they lower your overall blood pressure and specifically reduce the pressure inside your kidneys’ filtering units. ACE inhibitors and ARBs both work by blocking a hormone called angiotensin II, which narrows blood vessels throughout the body but especially in the kidneys. When there’s too much of this hormone, the blood vessels in your kidneys can’t relax, and the resulting high pressure accelerates damage.
ACE inhibitors reduce how much angiotensin II your body produces, while ARBs block the receptors it latches onto. The result is the same: your kidney blood vessels relax, filtering pressure drops, and less protein leaks into the urine. Protein in the urine (albuminuria) is both a sign of kidney damage and a driver of further damage, so reducing it is a key goal. Your doctor will check your potassium levels before starting either medication and again a few weeks later, since these drugs can raise potassium. The two types are not used together because the combination increases side effects without additional benefit.
SGLT2 Inhibitors
Originally developed for diabetes, SGLT2 inhibitors have turned out to be one of the most important advances in kidney protection in decades. They work by changing how the kidneys handle sugar and salt, which reduces the pressure inside the filtering units through a different pathway than ACE inhibitors or ARBs. This means the two can be used together for a combined protective effect.
A large meta-analysis found that SGLT2 inhibitors reduced the risk of kidney disease progression by 23% compared to placebo in people with existing chronic kidney disease. These medications now have approval for kidney protection regardless of whether you have diabetes. The benefit appears within weeks of starting treatment, and some people notice an initial small dip in kidney function that stabilizes quickly. This early dip actually reflects reduced pressure on the filtering units and is considered a sign the drug is working as intended.
Finerenone for Diabetic Kidney Disease
If you have both type 2 diabetes and kidney disease with protein in your urine, a newer medication called finerenone may offer additional protection. It blocks a hormone receptor involved in inflammation and scarring in the kidneys and heart. Unlike older drugs in its class (like spironolactone), finerenone works primarily by reducing inflammation and fibrosis in kidney tissue rather than just lowering blood pressure.
The FIDELIO-DKD trial showed that finerenone significantly reduced the risk of kidney disease progression in people with diabetic kidney disease, particularly those with high levels of protein in their urine. When combined with an SGLT2 inhibitor, the results are even more striking. A phase 2 trial found that using both medications together reduced urinary protein levels by 52% at six months, roughly 30% more than either drug achieved alone. This combination approach, layering medications that target different parts of the damage cycle, represents the current frontier of kidney protection.
Manage Blood Sugar Carefully
For people with diabetes, blood sugar control is foundational. High blood sugar damages the tiny blood vessels in the kidneys, triggers hyperfiltration, and fuels the inflammation that leads to scarring. The international KDIGO guideline recommends an individualized HbA1c target ranging from below 6.5% to below 8.0% for people with diabetes and kidney disease who are not on dialysis.
That range is intentionally wide because the right target depends on your situation. Tighter control (closer to 6.5%) offers more kidney protection but carries a higher risk of dangerously low blood sugar, which becomes more common as kidney function declines because the kidneys play a role in clearing diabetes medications from your body. If you’ve had episodes of low blood sugar, have other serious health conditions, or have limited life expectancy, a target closer to 8.0% may be safer and more appropriate.
Reduce Protein in Your Diet
Everything you eat that contains protein eventually produces nitrogen-containing waste products that your kidneys must filter out. When kidney function is reduced, a high-protein diet forces the remaining nephrons to work harder, accelerating the hyperfiltration cycle. Reducing protein intake eases this workload.
Current guidelines from KDOQI recommend that adults with stage 3 through 5 kidney disease (who are not on dialysis) limit protein to 0.55 to 0.60 grams per kilogram of body weight per day. For a 70-kilogram (154-pound) person, that’s roughly 39 to 42 grams of protein daily, considerably less than what most people eat. A very low protein diet of 0.28 to 0.43 grams per kilogram is sometimes used with special supplements called keto acid analogs to prevent malnutrition. This level of restriction requires close supervision from a dietitian, since getting too little protein carries its own risks, including muscle wasting.
The quality of protein matters too. Plant-based protein sources produce fewer of the waste products that stress the kidneys compared to animal protein, and diets emphasizing fruits, vegetables, and whole grains also help manage the acid load that damaged kidneys struggle to handle.
Limit Sodium Intake
Sodium directly raises blood pressure and increases the pressure inside your kidneys’ filtering units. It also blunts the effectiveness of ACE inhibitors, ARBs, and other kidney-protective medications. Most guidelines recommend keeping sodium below 2,000 milligrams per day. The biggest sources are processed foods, restaurant meals, and canned goods rather than the salt shaker on your table. Reading nutrition labels and cooking more meals at home are the most practical ways to cut back.
Avoid Medications That Harm the Kidneys
People with kidney disease are especially vulnerable to drugs that can cause acute kidney injury on top of their existing damage. NSAIDs, the category that includes ibuprofen and naproxen, are among the most common culprits. They reduce blood flow to the kidneys and can trigger sudden drops in function. Acetaminophen (Tylenol) is generally the safer alternative for pain relief.
The KDIGO guideline recommends avoiding or dose-adjusting nephrotoxic medications once your estimated GFR drops below 60, which corresponds to stage 3 or higher. Beyond NSAIDs, certain other medications may need adjustment or substitution. Always let every prescriber know your kidney function level, including dentists and urgent care providers who might not have your full medical history. Even some over-the-counter supplements and herbal products can be harmful, so check with your care team before adding anything new.
Stop Smoking
Smoking accelerates kidney disease through multiple pathways: it raises blood pressure, reduces blood flow to the kidneys, promotes inflammation, and worsens proteinuria. In a six-year study of healthy middle-aged workers, men who developed proteinuria (an early marker of kidney damage) lost an additional 3.4 points of kidney function compared to those who didn’t, regardless of smoking status. Smoking increases the likelihood of developing that proteinuria in the first place.
Quitting won’t reverse existing damage, but it removes one of the modifiable factors pushing the disease forward. The cardiovascular benefits of quitting are also especially relevant because heart disease is the leading cause of death in people with chronic kidney disease, far more common than kidney failure itself.
Putting It All Together
The most effective approach layers multiple strategies. A typical kidney-protective regimen for someone with moderate kidney disease might include an ACE inhibitor or ARB, an SGLT2 inhibitor, blood pressure kept below 130/80, reduced sodium and protein intake, tight but safe blood sugar control if diabetes is present, and avoidance of nephrotoxic medications. For those with diabetic kidney disease and significant protein in the urine, adding finerenone provides another layer of protection.
Each intervention targets a different part of the damage cycle, and their benefits add up. Regular monitoring of kidney function (through blood tests for eGFR and urine tests for protein) helps you and your care team track whether the current plan is working or needs adjustment. Small, sustained changes in the rate of decline can translate into years of preserved kidney function over a lifetime.